Patents by Inventor Saja Baraghithy

Saja Baraghithy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME
    Publication number: 20220000814
    Abstract: A method for treating Prader-Willi syndrome (PWS)-induced bone loss in a pediatric subject includes administering to the subject a therapeutically effective amount of a fatty acid amide of an amino acid, or a stereoisomer or salt thereof. Pharmaceutical compositions including a fatty acid amide of an amino acid, such as oleoyl-?-methyl-serine, or a stereoisomer or salt thereof, can be used for improving, i.e., increasing or preventing loss of, bone mineral density and/or treating osteoporosis in patients suffering from Prader-Willi syndrome.
    Type: Application
    Filed: July 12, 2021
    Publication date: January 6, 2022
    Inventors: Raphael Mechoulam, Joseph Tam, Reem Smoum, Saja Baraghithy
  • Methods for treatment of Prader-Willi syndrome
    Patent number: 11058652
    Abstract: The present disclosure provides pharmaceutical compositions comprising a fatty acid amide of an amino acid as defined herein, such as oleoyl-?-methyl-serine, or a stereoisomer or salt thereof, for improving, as in increasing or preventing loss of, bone mineral density and/or treating osteoporosis in patients suffering from Prader-Willi syndrome; and their methods of use.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: July 13, 2021
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Raphael Mechoulam, Joseph Tam, Reem Smoum, Saja Baraghithy
  • METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME
    Publication number: 20190151264
    Abstract: The present disclosure provides pharmaceutical compositions comprising a fatty acid amide of an amino acid as defined herein, such as oleoyl-?-methyl-serine, or a stereoisomer or salt thereof, for improving, as in increasing or preventing loss of, bone mineral density and/or treating osteoporosis in patients suffering from Prader-Willi syndrome; and their methods of use.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 23, 2019
    Inventors: Raphael Mechoulam, Joseph Tam, Reem Smoum, Saja Baraghithy